Life Planning Partners Inc bought a new stake in shares of RXO, Inc. (NYSE:RXO - Free Report) during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm bought 157,797 shares of the company's stock, valued at approximately $3,762,000. Life Planning Partners Inc owned about 0.10% of RXO at the end of the most recent quarter.
A number of other hedge funds and other institutional investors have also recently modified their holdings of the business. Blue Trust Inc. grew its position in RXO by 79.7% in the 4th quarter. Blue Trust Inc. now owns 1,150 shares of the company's stock worth $27,000 after purchasing an additional 510 shares during the period. Wilmington Savings Fund Society FSB purchased a new stake in shares of RXO in the 3rd quarter worth $28,000. Smartleaf Asset Management LLC increased its stake in shares of RXO by 228.4% in the 4th quarter. Smartleaf Asset Management LLC now owns 1,248 shares of the company's stock worth $30,000 after purchasing an additional 868 shares in the last quarter. Nomura Asset Management Co. Ltd. lifted its position in RXO by 68.7% during the third quarter. Nomura Asset Management Co. Ltd. now owns 1,400 shares of the company's stock valued at $39,000 after purchasing an additional 570 shares in the last quarter. Finally, Thurston Springer Miller Herd & Titak Inc. raised its stake in shares of RXO by 407.0% in the fourth quarter. Thurston Springer Miller Herd & Titak Inc. now owns 1,800 shares of the company's stock worth $43,000 after buying an additional 1,445 shares during the period. 92.73% of the stock is owned by institutional investors.
Analysts Set New Price Targets
A number of equities research analysts have issued reports on RXO shares. Wells Fargo & Company cut their price objective on shares of RXO from $22.00 to $20.00 and set an "equal weight" rating for the company in a report on Thursday, March 27th. The Goldman Sachs Group reduced their price target on RXO from $28.00 to $24.00 and set a "neutral" rating on the stock in a research report on Thursday, February 6th. Stifel Nicolaus decreased their price objective on shares of RXO from $27.00 to $24.00 and set a "hold" rating for the company in a research report on Thursday, February 6th. Truist Financial began coverage on shares of RXO in a research note on Thursday, March 13th. They set a "buy" rating and a $24.00 price objective for the company. Finally, Barclays cut their target price on RXO from $24.00 to $22.00 and set an "overweight" rating on the stock in a research report on Wednesday. Two research analysts have rated the stock with a sell rating, eleven have given a hold rating and four have issued a buy rating to the company. According to data from MarketBeat, the stock has an average rating of "Hold" and a consensus price target of $24.80.
Check Out Our Latest Stock Report on RXO
RXO Trading Down 12.1 %
NYSE RXO traded down $2.37 during trading on Thursday, hitting $17.18. The stock had a trading volume of 693,399 shares, compared to its average volume of 1,037,880. The company has a market capitalization of $2.81 billion, a PE ratio of -8.10, a PEG ratio of 4.55 and a beta of 1.67. RXO, Inc. has a twelve month low of $16.87 and a twelve month high of $32.82. The company has a quick ratio of 1.33, a current ratio of 1.26 and a debt-to-equity ratio of 0.22. The firm has a 50 day moving average price of $20.93 and a 200 day moving average price of $25.05.
RXO (NYSE:RXO - Get Free Report) last posted its quarterly earnings results on Wednesday, February 5th. The company reported $0.06 EPS for the quarter, hitting the consensus estimate of $0.06. RXO had a negative net margin of 6.26% and a positive return on equity of 1.53%. As a group, equities research analysts forecast that RXO, Inc. will post 0.31 earnings per share for the current year.
About RXO
(
Free Report)
RXO, Inc provides full truckload freight transportation brokering services. It also offers brokered services for managed transportation, last mile, and freight forwarding. The company was incorporated in 2022 and is based in Charlotte, North Carolina.
Featured Articles
Before you consider RXO, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and RXO wasn't on the list.
While RXO currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for April 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
